دورية أكاديمية

Dupilumab Treatment is Not Associated with Increased Risk of Overall Skin Infections [Letter]

التفاصيل البيبلوغرافية
العنوان: Dupilumab Treatment is Not Associated with Increased Risk of Overall Skin Infections [Letter]
المؤلفون: Wiggins S, Levit NA
المصدر: ImmunoTargets and Therapy, Vol Volume 12, Pp 77-78 (2023)
بيانات النشر: Dove Medical Press, 2023.
سنة النشر: 2023
المجموعة: LCC:Immunologic diseases. Allergy
مصطلحات موضوعية: dupilumab, prurigo nodularis, skin infections, Immunologic diseases. Allergy, RC581-607
الوصف: Simmi Wiggins,1,* Noah A Levit2,* 1Sanofi, 410 Thames Valley Park Dr, Reading, RG6 1PT, UK; 2Regeneron Pharmaceuticals Inc, Tarrytown, NY, 10591, USA*These authors contributed equally to this workCorrespondence: Simmi Wiggins, Sanofi, 410 Thames Valley Park Dr, Reading, RG6 1PT, UK, Tel +44 (0) 1183 543 000, Fax +44 (0) 800 471 8627, Email Simmi.Wiggins@sanofi.com
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 2253-1556
العلاقة: https://www.dovepress.com/dupilumab-treatment-is-not-associated-with-increased-risk-of-overall-s-peer-reviewed-fulltext-article-ITTTest; https://doaj.org/toc/2253-1556Test
الوصول الحر: https://doaj.org/article/01cdf78ce9284550baab66bcf8a3ed86Test
رقم الانضمام: edsdoj.01cdf78ce9284550baab66bcf8a3ed86
قاعدة البيانات: Directory of Open Access Journals